单次接种具有大阪突变的β -淀粉样蛋白种子后淀粉样蛋白病理、脑功能和认知的长期恶化。

IF 6.2 2区 医学 Q1 NEUROSCIENCES
Marina Célestine, Muriel Jacquier-Sarlin, Eve Borel, Fanny Petit, Jean-Baptiste Perot, Anne-Sophie Hérard, Luc Bousset, Alain Buisson, Marc Dhenain
{"title":"单次接种具有大阪突变的β -淀粉样蛋白种子后淀粉样蛋白病理、脑功能和认知的长期恶化。","authors":"Marina Célestine,&nbsp;Muriel Jacquier-Sarlin,&nbsp;Eve Borel,&nbsp;Fanny Petit,&nbsp;Jean-Baptiste Perot,&nbsp;Anne-Sophie Hérard,&nbsp;Luc Bousset,&nbsp;Alain Buisson,&nbsp;Marc Dhenain","doi":"10.1186/s40478-023-01559-0","DOIUrl":null,"url":null,"abstract":"<p><p>Alzheimer's disease (AD) is characterized by intracerebral deposition of abnormal proteinaceous assemblies made of amyloid-β (Aß) peptides or tau proteins. These peptides and proteins induce synaptic dysfunctions that are strongly correlated with cognitive decline. Intracerebral infusion of well-defined Aβ seeds from non-mutated Aβ<sub>1-40</sub> or Aβ<sub>1-42</sub> peptides can increase Aβ depositions several months after the infusion. Familial forms of AD are associated with mutations in the amyloid precursor protein (APP) that induce the production of Aβ peptides with different structures. The Aβ Osaka (Aβ<sub>osa</sub> mutation (E693Δ)) is located within the Aβ sequence and thus the Aβ<sub>osa</sub> peptides have different structures and properties as compared to non-mutated Aβ<sub>1-42</sub> peptides (Aβ<sub>wt</sub>). Here, we wondered if a single exposure to this mutated Aβ can worsen AD pathology as well as downstream events including cognition, cerebral connectivity and synaptic health several months after the inoculation. To answer this question we inoculated Aβ<sub>1-42</sub>-bearing Osaka mutation (Aβ<sub>osa</sub>) in the dentate gyrus of APP<sub>swe</sub>/PS1<sub>dE9</sub> mice at the age of two months. Their cognition and cerebral connectivity were analyzed at 4 months post-inoculation by behavioral evaluation and functional MRI. Aβ pathology as well as synaptic density were evaluated by histology. The impact of Aβ<sub>osa</sub> peptides on synaptic health was also measured on primary cortical neurons. Remarkably, the intracerebral administration of Aβ<sub>osa</sub> induced cognitive and synaptic impairments as well as a reduction of functional connectivity between different brain regions, 4 months post-inoculation. It increased Aβ plaque depositions and increased Aβ oligomers. This is the first study showing that a single, sporadic event as Aβ<sub>osa</sub> inoculation can worsen the fate of the pathology and clinical outcome several months after the event. It suggests that a single inoculation of Aβ regulates a large cascade of events for a long time.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":"11 1","pages":"66"},"PeriodicalIF":6.2000,"publicationDate":"2023-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122826/pdf/","citationCount":"0","resultStr":"{\"title\":\"Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation.\",\"authors\":\"Marina Célestine,&nbsp;Muriel Jacquier-Sarlin,&nbsp;Eve Borel,&nbsp;Fanny Petit,&nbsp;Jean-Baptiste Perot,&nbsp;Anne-Sophie Hérard,&nbsp;Luc Bousset,&nbsp;Alain Buisson,&nbsp;Marc Dhenain\",\"doi\":\"10.1186/s40478-023-01559-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Alzheimer's disease (AD) is characterized by intracerebral deposition of abnormal proteinaceous assemblies made of amyloid-β (Aß) peptides or tau proteins. These peptides and proteins induce synaptic dysfunctions that are strongly correlated with cognitive decline. Intracerebral infusion of well-defined Aβ seeds from non-mutated Aβ<sub>1-40</sub> or Aβ<sub>1-42</sub> peptides can increase Aβ depositions several months after the infusion. Familial forms of AD are associated with mutations in the amyloid precursor protein (APP) that induce the production of Aβ peptides with different structures. The Aβ Osaka (Aβ<sub>osa</sub> mutation (E693Δ)) is located within the Aβ sequence and thus the Aβ<sub>osa</sub> peptides have different structures and properties as compared to non-mutated Aβ<sub>1-42</sub> peptides (Aβ<sub>wt</sub>). Here, we wondered if a single exposure to this mutated Aβ can worsen AD pathology as well as downstream events including cognition, cerebral connectivity and synaptic health several months after the inoculation. To answer this question we inoculated Aβ<sub>1-42</sub>-bearing Osaka mutation (Aβ<sub>osa</sub>) in the dentate gyrus of APP<sub>swe</sub>/PS1<sub>dE9</sub> mice at the age of two months. Their cognition and cerebral connectivity were analyzed at 4 months post-inoculation by behavioral evaluation and functional MRI. Aβ pathology as well as synaptic density were evaluated by histology. The impact of Aβ<sub>osa</sub> peptides on synaptic health was also measured on primary cortical neurons. Remarkably, the intracerebral administration of Aβ<sub>osa</sub> induced cognitive and synaptic impairments as well as a reduction of functional connectivity between different brain regions, 4 months post-inoculation. It increased Aβ plaque depositions and increased Aβ oligomers. This is the first study showing that a single, sporadic event as Aβ<sub>osa</sub> inoculation can worsen the fate of the pathology and clinical outcome several months after the event. It suggests that a single inoculation of Aβ regulates a large cascade of events for a long time.</p>\",\"PeriodicalId\":6914,\"journal\":{\"name\":\"Acta Neuropathologica Communications\",\"volume\":\"11 1\",\"pages\":\"66\"},\"PeriodicalIF\":6.2000,\"publicationDate\":\"2023-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122826/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Neuropathologica Communications\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40478-023-01559-0\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neuropathologica Communications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40478-023-01559-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

阿尔茨海默病(AD)的特征是由淀粉样蛋白-β (β)肽或tau蛋白组成的异常蛋白组合在脑内沉积。这些多肽和蛋白质诱导突触功能障碍,与认知能力下降密切相关。在脑内灌注未突变的Aβ1-40或Aβ1-42肽的明确定义的Aβ种子可以在输注几个月后增加Aβ沉积。家族性AD与淀粉样蛋白前体蛋白(APP)的突变有关,该突变可诱导产生不同结构的Aβ肽。Aβ Osaka (Aβosa突变(E693Δ))位于Aβ序列内,因此与未突变的Aβ1-42肽(Aβwt)相比,Aβosa肽具有不同的结构和性质。在这里,我们想知道单次暴露于这种突变的a β是否会在接种后几个月恶化AD病理以及下游事件,包括认知、大脑连通性和突触健康。为了回答这个问题,我们在2月龄的APPswe/PS1dE9小鼠齿状回中接种了携带大阪突变的a β1-42 (Aβosa)。接种后4个月,通过行为评价和功能MRI分析他们的认知和大脑连通性。采用组织学方法观察Aβ病理变化及突触密度变化。Aβosa肽对初级皮质神经元突触健康的影响也被测量。值得注意的是,在接种后4个月,a βosa脑内注射可引起认知和突触损伤,并减少不同脑区之间的功能连接。它增加了Aβ斑块沉积和Aβ低聚物。这是第一个研究表明,接种a βosa等单一的散发事件可在事件发生几个月后恶化病理和临床结果的命运。这表明单次接种a β可以在很长一段时间内调节一系列大的连锁反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation.

Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation.

Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation.

Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation.

Alzheimer's disease (AD) is characterized by intracerebral deposition of abnormal proteinaceous assemblies made of amyloid-β (Aß) peptides or tau proteins. These peptides and proteins induce synaptic dysfunctions that are strongly correlated with cognitive decline. Intracerebral infusion of well-defined Aβ seeds from non-mutated Aβ1-40 or Aβ1-42 peptides can increase Aβ depositions several months after the infusion. Familial forms of AD are associated with mutations in the amyloid precursor protein (APP) that induce the production of Aβ peptides with different structures. The Aβ Osaka (Aβosa mutation (E693Δ)) is located within the Aβ sequence and thus the Aβosa peptides have different structures and properties as compared to non-mutated Aβ1-42 peptides (Aβwt). Here, we wondered if a single exposure to this mutated Aβ can worsen AD pathology as well as downstream events including cognition, cerebral connectivity and synaptic health several months after the inoculation. To answer this question we inoculated Aβ1-42-bearing Osaka mutation (Aβosa) in the dentate gyrus of APPswe/PS1dE9 mice at the age of two months. Their cognition and cerebral connectivity were analyzed at 4 months post-inoculation by behavioral evaluation and functional MRI. Aβ pathology as well as synaptic density were evaluated by histology. The impact of Aβosa peptides on synaptic health was also measured on primary cortical neurons. Remarkably, the intracerebral administration of Aβosa induced cognitive and synaptic impairments as well as a reduction of functional connectivity between different brain regions, 4 months post-inoculation. It increased Aβ plaque depositions and increased Aβ oligomers. This is the first study showing that a single, sporadic event as Aβosa inoculation can worsen the fate of the pathology and clinical outcome several months after the event. It suggests that a single inoculation of Aβ regulates a large cascade of events for a long time.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta Neuropathologica Communications
Acta Neuropathologica Communications Medicine-Pathology and Forensic Medicine
CiteScore
11.20
自引率
2.80%
发文量
162
审稿时长
8 weeks
期刊介绍: "Acta Neuropathologica Communications (ANC)" is a peer-reviewed journal that specializes in the rapid publication of research articles focused on the mechanisms underlying neurological diseases. The journal emphasizes the use of molecular, cellular, and morphological techniques applied to experimental or human tissues to investigate the pathogenesis of neurological disorders. ANC is committed to a fast-track publication process, aiming to publish accepted manuscripts within two months of submission. This expedited timeline is designed to ensure that the latest findings in neuroscience and pathology are disseminated quickly to the scientific community, fostering rapid advancements in the field of neurology and neuroscience. The journal's focus on cutting-edge research and its swift publication schedule make it a valuable resource for researchers, clinicians, and other professionals interested in the study and treatment of neurological conditions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信